License-, distribution-, and supply agreements for Pharma-, Biotech, and MedTech companies

• Rx and OTC
• Innovative medicines and biosimilars/generics
• Small molecules & biologics
• In the fields of sepsis, oncology, respiratory, inflammation, vaccines, neurology
• Early-, late stage-, and marketed products
• Delivery technologies & medical devices
• With academic and non-academic institutions

 

R&D cooperations

• Fee-for-Service cooperations
• Technology feasibility studies
• R&D collaborations under option agreement
• Co-development & Risk-share scenarios

 

Diverse agreements with CRO´s and CMO´s